Ischaemic heart disease

World-first ACE2 test could predict risk of myocardial infarction

Elevated plasma Angiotensin Converting Enzyme (ACE) 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease, University of Melbourne researchers have shown. The findings suggest that a simple blood test could identify patients most at risk of suffering a life-threatening cardiac event, after researchers found that high ...

Already a member?

Login to keep reading.

© 2021 the limbic